Adjuvant Capital
Entity

  • Adjuvant Capital

    Created in 2018
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    512 608 2,677

  • Entity types

    Incubators & VCs

  • Location

    Brooklyn, NY 11217, USA

    New York

    United States of America

  • Employees

    Scale: 2-10

    Estimated: 15

  • Engaged corporates

    6
    0 7

  • Added in Motherbase

    4 years, 8 months ago
Description
  • Value proposition

    Adjuvant Capital is the leading investment fund focused on public health.

    Adjuvant Capital is a life sciences investment firm focused on global health. We make $10-$25 million investments in ambitious companies targeting opportunities in high burden and neglected disease.

  • Adjuvant Capital

    Adjuvant is a life sciences investment fund that backs ambitious companies developing drugs, vaccines, diagnostics, medical devices, and other technologies to address critical global public health challenges.

    • https://adjuvantcapital.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Sofinnova Partners
Sofinnova Partners
Financial Services
Sofinnova Partners
Financial Services 		Other

31 Oct 2021


Novartis
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Novartis
Pharmaceutical, Pharmaceutical Manufacturing 		Other

18 Feb 2021


Johnson & Johnson
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care 		Other

31 Jan 2018


Energy Impact Partners
Energy Impact Partners
Venture Capital and Private Equity Principals
Energy Impact Partners
Venture Capital and Private Equity Principals 		Other

18 Nov 2021


KKR
KKR
Startup accelerator & VC, Financial Services
KKR
Startup accelerator & VC, Financial Services 		Other

18 Feb 2020


Omnes
Omnes
Startup accelerator & VC, Financial Services
Omnes
Startup accelerator & VC, Financial Services 		Other

5 Jan 2018


Similar entities
Last news
Show all articles
Social network dynamics